Free Trial
NASDAQ:AMED

Amedisys (AMED) Stock Price, News & Analysis

Amedisys logo
$97.52 +0.05 (+0.05%)
As of 12:32 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Amedisys Stock (NASDAQ:AMED)

Key Stats

Today's Range
$97.45
$97.71
50-Day Range
$93.43
$98.39
52-Week Range
$82.15
$98.95
Volume
59,751 shs
Average Volume
412,203 shs
Market Capitalization
$3.20 billion
P/E Ratio
35.99
Dividend Yield
N/A
Price Target
$100.75
Consensus Rating
Hold

Company Overview

Amedisys Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

AMED MarketRank™: 

Amedisys scored higher than 58% of companies evaluated by MarketBeat, and ranked 475th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Amedisys has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 1 buy rating, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Amedisys has received no research coverage in the past 90 days.

  • Read more about Amedisys' stock forecast and price target.
  • Earnings Growth

    Earnings for Amedisys are expected to grow by 10.00% in the coming year, from $4.40 to $4.84 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Amedisys is 35.99, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 26.52.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Amedisys is 35.99, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.09.

  • Price to Earnings Growth Ratio

    Amedisys has a PEG Ratio of 1.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Amedisys has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Amedisys' valuation and earnings.
  • Percentage of Shares Shorted

    6.77% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Amedisys has recently increased by 9.64%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Amedisys does not currently pay a dividend.

  • Dividend Growth

    Amedisys does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.77% of the float of Amedisys has been sold short.
  • Short Interest Ratio / Days to Cover

    Amedisys has a short interest ratio ("days to cover") of 5.4.
  • Change versus previous month

    Short interest in Amedisys has recently increased by 9.64%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Amedisys has a news sentiment score of 1.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 5 news articles for Amedisys this week, compared to 5 articles on an average week.
  • Search Interest

    13 people have searched for AMED on MarketBeat in the last 30 days. This is an increase of 550% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Amedisys insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Amedisys is held by insiders.

  • Percentage Held by Institutions

    94.36% of the stock of Amedisys is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Amedisys' insider trading history.
Receive AMED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Amedisys and its competitors with MarketBeat's FREE daily newsletter.

AMED Stock News Headlines

Bitcoin just humbled Jeff Bezos
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
Amedisys Executive Makes Notable Stock Sale
See More Headlines

AMED Stock Analysis - Frequently Asked Questions

Amedisys' stock was trading at $90.79 on January 1st, 2025. Since then, AMED stock has increased by 7.4% and is now trading at $97.5150.

Amedisys, Inc. (NASDAQ:AMED) released its earnings results on Wednesday, April, 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.13 by $0.12. The business's revenue was up 4.1% on a year-over-year basis.

Amedisys' top institutional investors include State of Alaska Department of Revenue (0.06%), Public Employees Retirement System of Ohio (0.06%), Parallel Advisors LLC (0.03%) and Exchange Traded Concepts LLC (0.03%).
View institutional ownership trends
.

Shares of AMED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Amedisys investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
4/23/2025
Today
7/18/2025
Next Earnings (Estimated)
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - OUTP/HM CRE
Sub-Industry
Health Care Services
Current Symbol
NASDAQ:AMED
CIK
896262
Employees
19,000
Year Founded
1982

Price Target and Rating

High Price Target
$101.00
Low Price Target
$100.00
Potential Upside/Downside
+3.4%
Consensus Rating
Hold
Rating Score (0-4)
2.25
Research Coverage
4 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.71
Trailing P/E Ratio
35.97
Forward P/E Ratio
22.15
P/E Growth
1.32
Net Income
$43.23 million
Net Margins
3.79%
Pretax Margin
6.33%
Return on Equity
12.52%
Return on Assets
7.01%

Debt

Debt-to-Equity Ratio
0.27
Current Ratio
1.29
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$2.35 billion
Price / Sales
1.36
Cash Flow
$6.23 per share
Price / Cash Flow
15.64
Book Value
$36.03 per share
Price / Book
2.71

Miscellaneous

Outstanding Shares
32,820,000
Free Float
32,131,000
Market Cap
$3.20 billion
Optionable
Optionable
Beta
0.94

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:AMED) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners